<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03744078</url>
  </required_header>
  <id_info>
    <org_study_id>47</org_study_id>
    <nct_id>NCT03744078</nct_id>
  </id_info>
  <brief_title>A Randomized Trial of Induction Methods in Premature Rupture of Membranes</brief_title>
  <official_title>A Randomized Trial of Foley Bulb and PGE2 for Labor Induction in Premature Rupture of Membranes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zeynep Kamil Maternity and Pediatric Research and Training Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zeynep Kamil Maternity and Pediatric Research and Training Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the addition of transcervical Foley catheter balloon and vaginal
      prostaglandin E2 induction in premature rupture of membranes. Half of participants will be
      used combine transcervical Foley catheter balloon and vaginal prostaglandin E2, while the
      other half will be used alone vaginal prostaglandin E2.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>induction-to- delivery time</measure>
    <time_frame>an average of one year</time_frame>
    <description>the length of time between the beginning of induction and the end of labor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>tachysystole</measure>
    <time_frame>an average of one year</time_frame>
    <description>uterine contractions more than 3 in 10 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>chorioamnionitis</measure>
    <time_frame>an average of one year</time_frame>
    <description>clinical chorioamnionitis(Maternal fever and Fetal tachycardia &gt;160/min and Maternal tachycardia &gt;100/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postpartum hemorrhage</measure>
    <time_frame>an average of one year</time_frame>
    <description>abnormal uterine bleeding after birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal outcome</measure>
    <time_frame>an average of one year</time_frame>
    <description>APGAR scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>admission to neonatal intensive care unit</measure>
    <time_frame>an average of one year</time_frame>
    <description>admission to neonatal intensive care unit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Preterm Premature Rupture of Fetal Membranes</condition>
  <condition>Induction of Labor Affected Fetus / Newborn</condition>
  <arm_group>
    <arm_group_label>PGE2 with Foley balloon catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 mg PGE2 vaginal ovul will be inserted to the posterior fornix and an 18-F Foley catheter which filling with 60 mL of saline solution will be placed into the cervix</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PGE2 vaginal ovule</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>10 mg PGE2 vaginal ovule will be inserted to the posterior fornix</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Foley balloon catheter</intervention_name>
    <description>18-F Foley catheter which filling with 60 mL of saline solution will be placed into the cervix</description>
    <arm_group_label>PGE2 with Foley balloon catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. singleton pregnancy,

          2. gestational age ≥34 weeks,

          3. rupture of membranes,

          4. cephalic presentation,

          5. bishop score ≤5,

          6. had less than three uterine contractions in every 10 minutes.

        Exclusion Criteria:

          1. Patients who had contraindications for vaginal delivery,

          2. previous uterine surgery,

          3. fetal malpresentation,

          4. multifetal pregnancy,

          5. more than three contractions in 10 minutes,

          6. contraindications to prostaglandins,

          7. a category II or III fetal heart rate pattern,

          8. anomalous fetus,

          9. fetal demise

         10. women with immediate delivery indications -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ahmet eser</last_name>
    <role>Study Director</role>
    <affiliation>Zeynep Kamil Maternity and Children's Training and Research Hospital, Department of Obstetrics and Gynecology, Istanbul, Turkey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ahmet eser</last_name>
    <phone>905067136880</phone>
    <email>hicoice@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>and yavuz</last_name>
    <phone>905062224075</phone>
    <email>andyavuz@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Doga</name>
      <address>
        <city>Istanbul</city>
        <state>Kucukcekmece</state>
        <zip>34303</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doga Seckin</last_name>
      <phone>905065152715</phone>
      <email>doga_seckin@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Doga Seckin</last_name>
    </contact_backup>
    <investigator>
      <last_name>Doga Seckin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zeynep Kamil Education and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <state>Uskudar</state>
        <zip>34668</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ahmet eser</last_name>
      <phone>905067136880</phone>
      <email>hicoice@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>ahmet eser</last_name>
      <email>hicoice@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>March 27, 2018</study_first_submitted>
  <study_first_submitted_qc>November 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2018</study_first_posted>
  <last_update_submitted>November 14, 2018</last_update_submitted>
  <last_update_submitted_qc>November 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zeynep Kamil Maternity and Pediatric Research and Training Hospital</investigator_affiliation>
    <investigator_full_name>Ahmet Eser</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

